Targeting RPS6KC1 to overcome enzalutamide resistance in prostate cancer.

Saved in:
Bibliographic Details
Title: Targeting RPS6KC1 to overcome enzalutamide resistance in prostate cancer.
Authors: Ji FH; Department of Urology, Ren-Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200001, People's Republic of China.; Department of Urology, School of Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, 200062, People's Republic of China., Qian YH; Department of Urology, Shanghai 411 Hospital, China Rong Tong Medical Healthcare Group Co. Ltd., Shanghai, 200081, People's Republic of China.; Department of Urology, School of Medicine, Xin-Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, People's Republic of China., Guo XC; Department of Urology, School of Medicine, Xin-Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, People's Republic of China., Liao HH; Department of Urology, School of Medicine, Xin-Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, People's Republic of China., Huang JC; Department of Urology, School of Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, 200062, People's Republic of China., Xu ZH; Department of Urology, School of Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, 200062, People's Republic of China., Yu MM; Department of Urology, School of Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, 200062, People's Republic of China.; Department of Ultrasound in Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China., Wu YY; Department of Urology, School of Medicine, Xin-Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, People's Republic of China. tiffany019@163.com., Bao JW; Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, People's Republic of China. baojiewen@126.com., Chen HJ; Department of Urology, School of Medicine, Xin-Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, People's Republic of China. chjm416@163.com.; Department of Urology, School of Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, 200062, People's Republic of China. chjm416@163.com., Yu YJ; Department of Urology, School of Medicine, Xin-Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, People's Republic of China. yuyongjiang@xinhuamed.com., Wang L; Department of Urology, Ren-Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200001, People's Republic of China. wanglinbyg@163.com.; Department of Urology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, People's Republic of China. wanglinbyg@163.com.
Source: Biomarker research [Biomark Res] 2025 Aug 23; Vol. 13 (1), pp. 109. Date of Electronic Publication: 2025 Aug 23.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101607860 Publication Model: Electronic Cited Medium: Print ISSN: 2050-7771 (Print) Linking ISSN: 20507771 NLM ISO Abbreviation: Biomark Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2050-7771
DOI:10.1186/s40364-025-00822-x